Reaktionsgleichung
C([O:5][C:6](=[O:35])[C:7]([O:10][C:11]1[CH:16]=[CH:15][C:14]([CH2:17][CH2:18][CH2:19][CH:20]2[CH2:24][N:23]([CH2:25][C:26]3[CH:31]=[CH:30][C:29]([CH3:32])=[C:28]([CH3:33])[CH:27]=3)[C:22](=[O:34])[NH:21]2)=[CH:13][CH:12]=1)([CH3:9])[CH3:8])(C)(C)C.FC(F)(F)C(O)=O>C(Cl)Cl>[CH3:33][C:28]1[CH:27]=[C:26]([CH:31]=[CH:30][C:29]=1[CH3:32])[CH2:25][N:23]1[CH2:24][CH:20]([CH2:19][CH2:18][CH2:17][C:14]2[CH:15]=[CH:16][C:11]([O:10][C:7]([CH3:9])([CH3:8])[C:6]([OH:35])=[O:5])=[CH:12][CH:13]=2)[NH:21][C:22]1=[O:34]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
A solution of 2-(4-{3-[1-(3,4-dimethyl-benzyl)-2-oxo-imidazolidin-4-yl]-propyl}-phenoxy)-2-methyl-propionic acid tert-butyl ester (0.051 g, 0.106 mmol) in CH2Cl2 (3 mL) was treated with trifluoroacetic acid (0.5 mL) and stirred at room temperature under N2 for 5 h. The solvent removed in vacuo to give crude acid that was purified by flash chromatography using 94:6 CH2Cl2:MeOH to afford 0.011 g (24%) 2-(4-{3-[1-(3,4-dimethyl-benzyl)-2-oxo-imidazolidin-4-yl]-propyl}-phenoxy) -2-methyl-propionic acid. MS (ES+) Calc'd for C25H33N2O4 (M+1) 425. Found m/z 425 (100%). 1H NMR.
Aufarbeitung
- customThe solvent removed in vacuo
- customto give crude acid that
- customwas purified by flash chromatography
Quellen und Nachweise
- ORD-Eintrag
- ord-63854d25743f4357b5361d6f95f13c17
- Quelldatensatz
- uspto-grants-2009_06
- Patentnummer
- US07544812B2
Verknüpfte Notizen
Wird geladen…